Is Eli Lilly Stock a Buy?
Weight loss drugs, primarily GLP-1 agonists, have taken the healthcare industry and the stock market by storm. Leading pharmaceutical company Eli Lilly (NYSE: LLY) is a significant player in the space, helping explain why the stock has soared 250% over the past three years.
Investors who may want to buy shares have been left wondering if they're too late, or if there's more to Lilly than its headline-grabbing GLP-1 products.
So I dove into the company and came away impressed. While the stock might not be a slam-dunk buy today, here's why you might want to pay close attention to Eli Lilly.
Source Fool.com


